As a mage, I just want to pursue the truth

Chapter 141 Boiling
In Zheng Li's absence, only Cheng Gang went to Yanjing for the meeting on his behalf.

In the past two years, I have participated in many remote video conferences during meetings in Yanjing.

But only a few actually participate offline.

Especially since only Ke Chuang Biotechnology Co., Ltd. participated, it seems like this is the first time.

Endorphins had previously licensed patents to external parties because Ke Chuang Bio's production capacity could not keep up with demand.

The production process of endorphins has very high requirements for operators, takes a long time to train, and it also takes a long time to expand production capacity.

Secondly, due to the general environment at the time, the government hinted that Ke Chuang Bio should license the endorphin patent to others, at least to a group of domestic pharmaceutical companies, and they would pay the patent licensing fees.

Therefore, Ke Chuang Biotech decided to work together to authorize global biopharmaceutical companies, so that everyone can produce endorphins as long as they pay.

It is precisely because of this operation of Kechuang Biotechnology that year that American has always felt that Kechuang Biotechnology is an object worth striving for.

Therefore, at most, Ke Chuang Biotechnology will be put on the observation list, and there will be no direct sanctions.

Even if Kechuang Biotechnology makes revolutionary progress in lithium battery technology, America will not impose sanctions on it.

Because the top companies in lithium battery production are all in East Asia, including CATL and BYD in China, Panasonic in Japan, LG and Samsung in Korea, etc.

American has no involvement in the lithium battery manufacturing industry.

If Ke Chuang Bio develops semiconductors or artificial intelligence, it will definitely be sanctioned.

"Come on, Mr. Cheng, this is the first time we meet. I want to talk to you about the development of Kechuang Biotechnology in recent years and your future plans."

"Leader, Kechuang Bio is currently mainly a technology research and development company. Especially after the development of brain-computer connection technology, we have determined this route to operate the company through technology research and development patent licensing.

In the future, we will continue to increase investment in R&D, focusing on the two main axes of the company: biomedicine and brain-computer connection. "

"So what's up with the lithium battery this time? It doesn't seem to belong to biomedicine."

"Leader, lithium battery technology is a project that our chairman Zheng Li is personally in charge of at the Lion City R&D Center.

I don’t know if you know this, but Zheng Li is the founder of Kechuang Biotechnology and the main inventor of brain-computer connection and endorphins.”

"I have heard of this. He is a young talent. In fact, I also want to meet him. It's a pity that he is still in Singapore. However, after the previous incident, we have always asked our colleagues in the embassy to pay more attention to the safety of overseas Chinese."

This is indeed the case. After the invasion of the R&D center of CS Biotech in Singapore, there have been many more military attachés at the Chinese Embassy in Singapore.

“I am very grateful for the country’s continued support for Kechuang Biotechnology. This lithium battery technology also comes from the scientific research innovation of our chairman.

Mr. Zheng majored in mathematics. Even after he started his research and development work in the biomedical field, he never gave up his study of mathematics.

In fact, Ke Chuang Bio's brain-computer connection technology is essentially an advancement in mathematics, which is a noise reduction process for human brain wave signals.

Compared with other brain-computer connection manufacturers, our biggest advantage is that our algorithm is more advanced, and the brain wave signals can be accurately recognized by the computer after being processed by the algorithm.

The essence of this lithium battery technology innovation is also mathematics. Mr. Zheng himself is interested in the new energy industry. When reading the literature, he realized that the structure of lithium metal could be optimized.

So Mr. Zheng combined some topological structures in mathematics to optimize the structure of lithium metal, and achieved the current results.

Since I had already returned my mathematics knowledge to my teacher, I don’t remember which specific topological structure gave Mr. Zheng the inspiration.”

When Cheng Gang was studying for his doctorate, biocomputing was not popular yet, and the requirements for mathematics were far less than they are now. Not to mention that Cheng Gang has been away from the front line of scientific research for so many years, let alone topology, he probably has almost forgotten the advanced mathematics he learned in college.

"Hahaha, I totally understand. Then I have a question. How does the cost of Kechuang Biotechnology's lithium battery technology compare with the current mainstream positive electrode materials? How is its safety?"

“It is safer than the current mainstream positive electrode materials. We have improved the stability through the unique graphene material. The cost is expected to be about 20 to 30 percent higher than the current mainstream products.

As production capacity increases, costs will be reduced.”

Cheng Gang's answer was beyond the other party's expectation. The only price they could accept was twice as expensive. Even if it was twice as expensive as the current positive electrode materials, they would increase subsidies to promote it.

“Very good, you did a great job.

China's industrial upgrading depends on continuous technological innovation. In this regard, Kechuang Biotechnology is worthy of being the leader of the Science and Technology Innovation Board.

In addition, this is a rare opportunity to promote industrial progress. Do you plan to license the patent or build your own factory this time? "

"For patent licensing, we will only license patents to domestic Chinese companies in the early stages."

"Very good, it is a good thing that you are willing to support the progress of China's industry. We will also support Kechuang Biotechnology at the government level.

In addition, if you grant patent authorization to all battery manufacturers, I hope that Sinovation Biotech can take the lead in promoting the battery swapping standard.”

China's central bank will hold a huge amount of cash in 2022, waiting to release it to offset the impact of the Fed's interest rate hike.

Therefore, from the beginning of the year to the end of the year, we have been saying that we will invest money in the field of new infrastructure. What is new infrastructure? It includes areas such as East-West computing, 5G base stations, big data centers, and new energy vehicles. It is unrealistic to use real estate to stimulate economic development, so a new model is needed to take over the over-issued currency and transfer the over-issued currency to residents through the form of new infrastructure.

The lithium battery developed by Ke Chuang Biotechnology can have a positive impact on macroeconomic policies.

The increase in the penetration rate of new energy vehicles has led to a substantial increase in electricity consumption, and the construction of ultra-high voltage and green energy can be further promoted.

The battery replacement standard, which had been difficult to promote before, can now be promoted.

A big problem with new energy is that it takes time to charge. It takes five minutes to refuel and half an hour to charge.

Therefore, someone came up with a solution, which is to replace the battery. The new energy vehicle can go to the charging station and replace the dead battery with a charged battery, which also only takes five minutes.

China introduced national battery swapping standards as early as 2021.

However, the battery models and standards of different manufacturers are different, and there are differences between the batteries of old models and new models.

Even with national standards for battery swapping, battery swapping still cannot be promoted.

The battery swap industry is also part of the new infrastructure and can bear a large part of the over-issued currency.

"Okay, we will sign relevant requirements with each manufacturer, requiring them to use our technology to produce lithium batteries of the same standard."

Kechuang Bio's promotion of this matter is a market behavior, which is equivalent to exchanging interests for compromise among battery manufacturers.

Originally, Kechuang Biotechnology may only require battery manufacturers to pay economic benefits, but now that the state has intervened, battery manufacturers need to pay other benefits.

"There is another thing. As an excellent company, Kechuang Biotechnology can contact state-owned enterprises when it is short of funds. Whether it is CICC or Huaguo Investment, they are willing to provide you with help."

"The website of the National Patent Office of China shows that Sinovation Biotech has applied for a patent for a technology related to positive electrode materials for lithium-ion batteries. The applicant for the patent is Zheng Li, chairman of Sinovation Biotech, and the application was made in February 2023.

The patent specification states that this technology can increase the energy density of lithium metal batteries to a breakthrough 700Wh/kg, and can also improve battery stability.

Data released by Kechuang Biotechnology shows that the single-cell energy density of lithium-ion batteries using its new cathode material reaches 700 Wh/kg."

As soon as the news came out, Kechuang Bio's stock price hit the daily limit at the opening of the next morning's trading. All stocks in the salt lake lithium extraction sector and lithium mining sector were soaring.

Instead, it is battery manufacturers that are falling.

Because the current situation is completely unclear, there is no accurate information on whether Kechuang Biotechnology will license the patent or build its own factory for production.

The outside world can only speculate that Ke Chuang Bio will license the patent according to convention, but only a few people know whether it will be granted.

Battery manufacturers only fell slightly, but CATL fell sharply.

Since lithium batteries can achieve 700Wh/kg, the implementation of their sodium-ion battery technology will be even more distant.

Moreover, the amount of funds in the A-share market is so large. The daily limit of Kechuang Bio has had a siphon effect on other large-cap stocks, and all the funds have been sucked away.

Both CATL and Moutai are falling, but CATL is falling more sharply.

“Science Biotech is worthy of its name. I bought a share when it went public and it was really a good buy. I kept it for my daughter as a gift when she comes of age.

The only thing I regret is not buying more. "

"I never thought that you, a guy with thick eyebrows and big eyes, would also go into new energy? It turns out that the turmoil in the salt lake lithium extraction sector was all because of you."

"It is 100% certain that the news was leaked in advance, and these organizations jumped on the opportunity."

"The technology is still on paper and is still far from being put into practice. It remains to be seen whether Kechuang Biotechnology's cathode materials can be put into practice on a large scale."

"The capital market has reacted so strongly. It has been rising for a month since the end of January. It must be able to be implemented on a large scale, otherwise the reaction would not be so strong."

"Science Bio is amazing. It is a rare company in China that truly possesses core technologies. Fortunately, there are these technology companies, so that the Chinese stock market is not filled with Jiangxiang Technology and Luzhou Technology."

"Science Biotechnology has this kind of good news every year. It's really good news all the time. You should know that this year Science Biotechnology will also launch brain-computer connection VR. I feel that the current valuation is still low."

The domestic propaganda has always been that the U.S. stock market is a bubble, but in fact the valuations of the giant companies in the U.S. stock market are not high.

On the contrary, the valuations of many Chinese companies are skyrocketing.

To give a very simple example, TSMC's dynamic price-to-earnings ratio is 26.6, while its benchmark SMIC's price-to-earnings ratio is about 47.

However, SMIC does have greater room for improvement.

Not only did the stock market respond enthusiastically, the new positive electrode material developed by Ke Chuang Biotechnology also made the industry even more excited.

(End of this chapter)